Seguir
Deepak Voora
Deepak Voora
Department of Veterans Affairs; Duke University Medical Center
Dirección de correo verificada de duke.edu
Título
Citado por
Citado por
Año
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ...
Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008
9922008
The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
D Voora, SH Shah, I Spasojevic, S Ali, CR Reed, BA Salisbury, ...
Journal of the American college of cardiology 54 (17), 1609-1616, 2009
5442009
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update
LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ...
Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014
4592014
The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy
RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ...
Clinical Pharmacology & Therapeutics 92 (1), 112-117, 2012
3622012
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ...
JACC: Cardiovascular Interventions 11 (2), 181-191, 2018
2712018
Phenotype standardization for statin‐induced myotoxicity
A Alfirevic, D Neely, J Armitage, H Chinoy, RG Cooper, R Laaksonen, ...
Clinical Pharmacology & Therapeutics 96 (4), 470-476, 2014
2462014
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
D Voora, C Eby, MW Linder, PE Milligan, BL Bukaveckas, HL McLeod, ...
Thrombosis and haemostasis 93 (04), 700-705, 2005
2422005
Genetic-based dosing in orthopedic patients beginning warfarin therapy
EA Millican, PA Lenzini, PE Milligan, L Grosso, C Eby, E Deych, G Grice, ...
Blood, The Journal of the American Society of Hematology 110 (5), 1511-1515, 2007
2232007
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal …
RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ...
Clinical Pharmacology & Therapeutics 111 (5), 1007-1021, 2022
1722022
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
C Varenhorst, N Eriksson, A Johansson, BJ Barratt, E Hagström, ...
European heart journal 36 (29), 1901-1912, 2015
1452015
A host-based RT-PCR gene expression signature to identify acute respiratory viral infection
AK Zaas, T Burke, M Chen, M McClain, B Nicholson, T Veldman, EL Tsalik, ...
Science translational medicine 5 (203), 203ra126-203ra126, 2013
1422013
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans
D Voora, DC Koboldt, CR King, PA Lenzini, CS Eby, R Porche‐Sorbet, ...
Clinical Pharmacology & Therapeutics 87 (4), 445-451, 2010
1252010
The pharmacogenetics of coumarin therapy
D Voora, HL McLeod, C Eby, BF Gage
Pharmacogenomics 6 (5), 503-513, 2005
1252005
Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response
D Voora, SH Shah, CR Reed, J Zhai, DR Crosslin, C Messer, ...
Circulation: Cardiovascular Genetics 1 (2), 100-106, 2008
1072008
Clinical application of cardiovascular pharmacogenetics
D Voora, GS Ginsburg
Journal of the American College of Cardiology 60 (1), 9-20, 2012
1012012
The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting
LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ...
Clinical and translational science 10 (3), 143, 2017
922017
Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: the PRIME care randomized clinical …
DW Oslin, KG Lynch, MC Shih, EP Ingram, LO Wray, SR Chapman, ...
Jama 328 (2), 151-161, 2022
872022
Platelets amplify endotheliopathy in COVID-19
TJ Barrett, MI Cornwell, K Myndzar, CC Rolling, Y Xia, K Drenkova, ...
Science Advances 7 (37), eabh2434, 2021
832021
Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter‐directed atrial fibrillation ablation
TW Wallace, BD Atwater, JP Daubert, D Voora, AL Crowley, TD Bahnson, ...
Journal of cardiovascular electrophysiology 21 (8), 849-852, 2010
832010
Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events
D Voora, D Cyr, J Lucas, JT Chi, J Dungan, TA McCaffrey, R Katz, ...
Journal of the American College of Cardiology 62 (14), 1267-1276, 2013
822013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20